Search Results - "Hospitaliers" :: UTM Library Massive Scholar Tracking

3441

Toenail Onychomycosis with or without Diabetes in Canada: Patient Treatment Preferences and Health State Utilities by Mickle AT, Lozano-Ortega G, Gaudet V, Popoff E, Barbeau M, Mathieu S

Published 2024-02-01

“…Alexis T Mickle,1 Greta Lozano-Ortega,1 Veronique Gaudet,2 Evan Popoff,1 Martin Barbeau,2 Steve Mathieu3 1Broadstreet Health Economics & Outcomes Research, Vancouver, British Columbia, Canada; 2Market Access and Government Affairs, Bausch Health, Canada Inc., Laval, Québec, Canada; 3Service de Dermatologie, Centre hospitalier de l’Université de Québec–Université Laval, Québec, Québec, CanadaCorrespondence: Greta Lozano-Ortega, Broadstreet Health Economics and Outcomes Research, 201 – 343 Railway Street, Vancouver, British Columbia, Canada, V6A 1A4, Tel +1 604-679-8000, Email glozano-ortega@broadstreetheor.comBackground: Toenail onychomycosis affects approximately 6.7% of Canadians. …”

Get full text

Article

3442

Epilepsy-Related Direct Medical and Direct Non-Medical Cost in Adult Patients Living with Epilepsy at a Tertiary Neurology Center in Rwanda by Teuwen DE, Sebera F, Murekeyiteto A, Garrez I, Sanchez-Iriso E, Umwiringirwa J, Umuhoza G, Boon PAJM, Dedeken P

Published 2023-01-01

“…Dirk E Teuwen,1,2 Fidele Sebera,1,3,4 Alphonsine Murekeyiteto,5 Ieme Garrez,1,2 Eduardo Sanchez-Iriso,6 Josiane Umwiringirwa,3 Georgette Umuhoza,3 Paul AJM Boon,1,2 Peter Dedeken1,2,7 1Department of Neurology, Ghent University Hospital, Ghent, Belgium; 2 4Brain, Ghent University Hospital, Ghent, Belgium; 3Neurology Department, CARAES Neuro-Psychiatric Hospital, Kigali, Rwanda; 4Neurology Department, Centre Hospitalier Universitaire (CHU-K), Kigali, Rwanda; 5Pharmacy Department, CARAES Neuro-Psychiatric Hospital, Kigali, Rwanda; 6Department of Economics, Universidad Pública de Navarra, Pamplona-Iruña, Spain; 7Department of Neurology, Heilig Hart Ziekenhuis, Lier, BelgiumCorrespondence: Dirk E Teuwen, Email dirk.teuwen@uzgent.beObjective: Up to one in four patients living with epilepsy (PwE) mentions financial constraints as a reason for loss to follow-up at the Ndera tertiary neuropsychiatry hospital. …”

Get full text

Article

3443

Correlation between CT severity score and clinical severity of COVID-19 pneumonia in hospitalised patients in a tertiary care hospital, Tamilnadu by Monisha Anandhan, K M Aishwarya, R Sridhar, Ajith, Balasubramaniam Ramakrishnan, R Narasimhan

Published 2020-01-01

“…Background and Methods: Retrospective study was done on 56 hospitalied patients who were diagnosed with COVID-19 Pneumonia with gold standard RT PCR in Apollo Main Hospital, Greams road, Chennai. …”

Get full text

Article

3444

Issue with Evaluating Costs Over Time in a Context of Medical Guideline Changes: An Example in Myocardial Infarction Care Based on a Longitudinal Study from 1997 to 2018 by Villeneuve T, Trudel X, Gilbert-Ouimet M, Leclerc J, Milot A, Sultan-Taïeb H, Brisson C, Guertin JR

Published 2022-01-01

“…Tania Villeneuve,1 Xavier Trudel,1,2 Mahée Gilbert-Ouimet,2,3 Jacinthe Leclerc,4,5 Alain Milot,6 Hélène Sultan-Taïeb,7,8 Chantal Brisson,1,2 Jason Robert Guertin1,2 1Université Laval, Département de médecine sociale et préventive, Quebec City, Canada; 2Centre de recherche du Centre hospitalier universitaire de l’Université Laval, Quebec City, Canada; 3Université du Québec à Rimouski, Département des sciences de la santé, module des sciences infirmières, Lévis, Canada; 4Université du Québec à Trois-Rivières, Département des sciences infirmières, Trois-Rivières, Canada; 5Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Quebec City, Canada; 6Université Laval, Département de médecine, Quebec City, Canada; 7Université du Québec à Montréal (UQAM), School of Management, Montreal, Canada; 8CINBIOSE, Montreal, CanadaCorrespondence: Jason Robert GuertinCentre de recherche du CHU de Québec – Université Laval, Axe Santé des Populations et Pratiques Optimales en Santé, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, local J1-09B, Québec City, Québec, G1S 4L8, CanadaTel +1 418-682-7511, poste 82516Email jason.guertin@fmed.ulaval.caBackground: Cost studies appear sporadically in the scientific literature and are rarely revised unless drastic technological advancements occur. …”

Get full text

Article

3445

Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospe... by Giunta M, Gauvin Meunier LP, Nixon D, Steeves J, Noble J

Published 2022-08-01

“…Michel Giunta,1,2 Louis-Pierre Gauvin Meunier,3 Donald Nixon,4,5 Jeff Steeves,6 Jason Noble7,8 1GOGiunta Ophtalmologie, Sherbrooke, QC, Canada; 2Department of Surgery, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada; 3Institut de l’Œil des Laurentides, Boisbriand, QC, Canada; 4Northern Ontario School of Medicine, Barrie, ON, Canada; 5TriMed Eye Centre, Barrie, ON, Canada; 6Department of Ophthalmology and Visual Sciences, Dalhousie University, Rothesay, NB, Canada; 7Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada; 8Sunnybrook Health Sciences Centre, Toronto, ON, CanadaCorrespondence: Michel Giunta, GOGiunta Ophtalmologie, 20, 12e Avenue S., #200, Sherbrooke, Québec, J1G 2V4, Canada, Tel +1 819 563 6889, Email direction@gogiunta.comPurpose: To assess early real-world outcomes with brolucizumab in Canadian patients with neovascular age-related macular degeneration (nAMD) for which they previously received ≥ 1 anti-vascular endothelial growth factor (anti-VEGF) agent(s).Patients and Methods: This multisite, real-world, retrospective chart review included data from a consecutive sample of 73 patients who received brolucizumab for nAMD after treatment with ≥ 1 other anti-VEGF agents. …”

Get full text

Article

3446